{"cluster": 23, "subcluster": 190, "abstract_summ": "These results suggest that testing was a major limiting factor in assessing the extent of SARS-CoV-2 transmission during its initial invasion of the US.Differences in COVID-19 testing and tracing across countries, as well as changes in testing within each country over time, make it difficult to estimate the true (population) infection rate based on the confirmed number of cases obtained through RNA viral testing.In all cases the infection prevalence is significantly higher than what has been widely reported, with much higher community infection rates in all locations.Our simulations show that sampling biases in favor of patients with higher disease manifestation could significantly affect direct estimates of infection and fatality rates calculated from the numbers of confirmed cases and deaths, and serological testing can partially mitigate these biased estimates.In this paper we use a Bayesian Network (BN) model to estimate the Covid-19 infection prevalence rate (IPR) and infection fatality rate (IFR) for different countries and regions, where relevant data are available.Understanding the time path of the COVID-19 pandemic has been hampered by the absence of bounds on infection rates that are credible and informative.", "title_summ": "Bayesian Network Analysis of Covid-19 data reveals higher Infection Prevalence Rates and lower Fatality Rates than widely reportedEstimating unobserved SARS-CoV-2 infections in the United StatesEstimating the true (population) infection rate for COVID-19: A Backcasting Approach with Monte Carlo MethodsIncorporating and Addressing Testing Bias Within Estimates of Epidemic Dynamics for SARS-CoV-2Estimating the COVID-19 Infection Rate: Anatomy of an Inference ProblemBayesian adjustment for preferential testing in estimating the COVID-19 infection fatality rate: Theory and methodsEstimating the COVID-19 infection rate: Anatomy of an inference problemThe impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States", "title_abstract_phrases": "Bayesian adjustment for preferential testing in estimating the COVID-19 infection fatality rate: Theory and methodsA key challenge in estimating the infection fatality rate (IFR) of COVID-19 is determining the total number of cases.Estimating the COVID-19 infection rate: Anatomy of an inference problemAs a consequence of missing data on tests for infection and imperfect accuracy of tests, reported rates of cumulative population infection by the SARS CoV-2 virus are lower than actual rates of infection.These results suggest that testing was a major limiting factor in assessing the extent of SARS-CoV-2 transmission during its initial invasion of the US.Estimating the true (population) infection rate for COVID-19: A Backcasting Approach with Monte Carlo MethodsDifferences in COVID-19 testing and tracing across countries, as well as changes in testing within each country over time, make it difficult to estimate the true (population) infection rate based on the confirmed number of cases obtained through RNA viral testing.Bayesian Network Analysis of Covid-19 data reveals higher Infection Prevalence Rates and lower Fatality Rates than widely reportedWidely reported statistics on Covid-19 across the globe fail to take account of both the uncertainty of the data and possible explanations for this uncertainty.Our simulations show that sampling biases in favor of patients with higher disease manifestation could significantly affect direct estimates of infection and fatality rates calculated from the numbers of confirmed cases and deaths, and serological testing can partially mitigate these biased estimates."}